⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6100204 | 1.00 | — | — | |
| SCHEMBL6672719 | 1.00 | — | — | |
| SCHEMBL8019661 | 0.76 | — | — | |
| SCHEMBL3598286 | 0.76 | — | — | |
| SCHEMBL8020137 | 0.76 | — | — | |
| SCHEMBL8975549 | 0.75 | — | — | |
| SCHEMBL11511608 | 0.75 | — | — | |
| SCHEMBL686736 | 0.75 | — | — | |
| SCHEMBL1876074 | 0.75 | — | — | |
| SCHEMBL8018383 | 0.75 | BHMT (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3180390-B1 | POLYMER FOR TISSUE ENGINEERING | UNIV LINZ (AT) | 2020-11-25 | — | — | EP | claimed |
| US-10815340-B2 | Polymer for tissue engineering | Universität Linz (AT) | 2020-10-27 | — | — | US | claimed |
| US-20170183453-A1 | POLYMER FOR TISSUE ENGINEERING | UNIVERSITAT LINZ (AT) | 2017-06-29 | — | — | US | claimed |
| EP-3180390-A1 | POLYMER FOR TISSUE ENGINEERING | Universität Linz (AT) | 2017-06-21 | — | — | EP | claimed |
| EP-2809647-B1 | MGLU 2/3 AGONISTS | LILLY CO ELI (US) | 2016-07-06 | — | — | EP | claimed |
| EP-2721012-B1 | BICYCLO(3.1.0)HEXANE-2,6-DICARBOXYLIC ACID DERIVATIVES AS MGLU2 RECEPTOR AGONIST | LILLY CO ELI (US) | 2016-05-25 | — | — | EP | claimed |
| US-9296710-B2 | Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist | ELI LILLY AND COMPANY (US) | 2016-03-29 | — | — | US | claimed |
| WO-2015192158-A1 | POLYMER FOR TISSUE ENGINEERING | Universität Linz (AT) | 2015-12-23 | — | — | WO | claimed |
| US-9187515-B2 | 2′,4′-fluoro nucleosides for the treatment of HCV | IDENIX PHARMACEUTICALS LLC (US) | 2015-11-17 | — | — | US | claimed |
| US-20140113944-A1 | BICYCLO (3.1.0) HEXANE-2, 6-DICARBOXYLIC ACID DERIVATIVES AS MGLU2 RECEPTOR AGONIST | ELI LILLY AND COMPANY (US) | 2014-04-24 | — | — | US | claimed |
| EP-0751779-A1 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORPORATION (US) | 1997-01-08 | — | — | EP | claimed |
| WO-1995034303-A1 | METHOD FOR THE TREATMENT, PREVENTION OR MINIMIZATION OF HAIR LOSS | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-12-21 | — | — | WO | claimed |
| WO-1995000165-A1 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORPORATION (US) | 1995-01-05 | — | — | WO | claimed |
| EP-0575482-A1 | ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE | EMORY UNIVERSITY (US) | 1993-12-29 | — | — | EP | claimed |
| WO-1992014743-A2 | ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE | EMORY UNIVERSITY (US) | 1992-09-03 | — | — | WO | claimed |
| EP-0237082-B1 | 3,5-DISUBSTITUTED 4,5-DIHYDROISOXAZOLES AS TRANSGLUTAMINASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1991-05-29 | — | — | EP | claimed |
| US-H810-H | MORPHINE AGONIST | Wilkinson, Samuel (GB) | 1990-08-07 | — | — | US | claimed |
| EP-0376012-A2 | Renin inhibitors | AMERICAN CYANAMID COMPANY (US) | 1990-07-04 | — | — | EP | claimed |
| EP-0237082-A2 | 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors | SYNTEX (U.S.A.) INC. (US) | 1987-09-16 | — | — | EP | claimed |
| US-4661443-A | FORMATION OF INITIAL NH2-TERMINAL DIPEPTIDES AND TRIPEPTIDES | HOFFMANN-LA ROCHE INC. (US) | 1987-04-28 | — | — | US | claimed |